{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:43:58Z","timestamp":1792622638167,"version":"4.5.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T00:00:00Z","timestamp":1738195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Prostate cancer remains a prevalent malignancy among men, often necessitating innovative therapeutic strategies for effective management of recurrent cases. This article examines the critical role of a biodegradable hydrogel spacer, which creates a temporary interspace between the prostate and the rectum, thus reducing radiation exposure to healthy tissues.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case description<\/jats:title><jats:p>We present a case of a man with a history of intermediate-risk prostate adenocarcinoma initially treated with external beam radiotherapy in 2015. Despite initial remission, the patient experienced a rise in prostate-specific antigen (PSA) levels indicative of local recurrence in 2022. Salvage treatment with iodine-125 brachytherapy, preceded by the placement of a rectal spacer in January 2024, resulted in a significant reduction of PSA levels. The patient remains asymptomatic with no urinary or gastrointestinal complications 6 months after the salvage treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Discussion<\/jats:title><jats:p>This case illustrates the complexities in managing recurrent prostate cancer and the evolving role of reirradiation strategies. Salvage iodine-125 brachytherapy with the placement of a rectal spacer provided precise radiation delivery while minimizing rectal toxicities. The significant biochemical response observed underscores the efficacy of this approach in controlling disease progression. The rectal spacer enhances treatment safety by reducing radiation exposure to adjacent tissues, highlighting its importance in reirradiation protocols. This case contributes to the growing evidence supporting the rectal spacer\u2019s role in enhancing the safety and efficacy of salvage brachytherapy for recurrent prostate cancer.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Our experience advocates for the integration of a hydrogel rectal spacer as a valuable tool in prostate cancer reirradiation protocols, offering a strategic approach to optimize treatment safety by minimizing rectal toxicity.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2025.1494304","type":"journal-article","created":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:10:09Z","timestamp":1738213809000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Case report of the first use of a hydrogel rectal spacer for prostate cancer reirradiation via LDR brachytherapy: applications and technical notes"],"prefix":"10.3389","volume":"15","author":[{"given":"Amina","family":"Lazrek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Finocchi Ghersi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeline","family":"Petre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Houabes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Agathe","family":"Serre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Gassa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Sandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecile","family":"Laude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Roukoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Cozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,1,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"394\u2212424","DOI":"10.3322\/caac.21492","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","first-page":"16\u221227","DOI":"10.1158\/1055-9965.EPI-15-0578","article-title":"Global cancer incidence and mortality rates and trends\u2014An update","volume":"25","author":"Torre","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B3","doi-asserted-by":"publisher","first-page":"777\u221285","DOI":"10.21873\/invivo.13141","article-title":"Moderately hypofractionated helical tomotherapy for prostate cancer: ten-year experience of a mono-institutional series of 415 patients","volume":"37","author":"Cozzi","year":"2023","journal-title":"In Vivo"},{"key":"B4","doi-asserted-by":"publisher","first-page":"102176","DOI":"10.1016\/j.ctrv.2021.102176","article-title":"Outcomes and toxicities of re-irradiation for prostate cancer: A systematic review on behalf of the Re-Irradiation Working Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"95","author":"Munoz","year":"2021","journal-title":"Cancer Treat Rev"},{"key":"B5","doi-asserted-by":"publisher","first-page":"554\u221264","DOI":"10.1007\/s00066-023-02043-3","article-title":"Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes","volume":"199","author":"Cozzi","year":"2023","journal-title":"Strahlenther Onkol"},{"key":"B6","first-page":"9288\u221293","article-title":"How I Do It: Hydrogel spacer placement in men scheduled to undergo prostate radiotherapy","volume":"25","author":"Montoya","year":"2018","journal-title":"Can J Urol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"976\u221285","DOI":"10.1016\/j.ijrobp.2016.12.024","article-title":"Continued benefit to rectal separation for prostate radiation therapy: final results of a phase III trial","volume":"97","author":"Hamstra","year":"2017","journal-title":"Int J Radiat Oncol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"700\u22129","DOI":"10.1007\/s00066-021-01871-5","article-title":"Prognostic factors, efficacy, and toxicity of involved-node stereotactic body radiation therapy for lymph node oligorecurrent prostate cancer: An investigation of 117 pelvic lymph nodes","volume":"198","author":"Cozzi","year":"2022","journal-title":"Strahlenther Onkol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1866\u221276","DOI":"10.3390\/curroncol29030152","article-title":"Adenoid cystic carcinoma\/basal cell carcinoma of the prostate: overview and update on rare prostate cancer subtypes","volume":"29","author":"Cozzi","year":"2022","journal-title":"Curr Oncol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1161\u221270","DOI":"10.1007\/s00345-020-03315-8","article-title":"Non-metastatic ductal adenocarcinoma of the prostate: pattern of care from an uro-oncology multidisciplinary group","volume":"39","author":"Bardoscia","year":"2021","journal-title":"World J Urol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"541\u221258","DOI":"10.1016\/j.canrad.2019.07.125","article-title":"Salvage reirradiation for local prostate cancer recurrence after radiation therapy. For who? When? How","volume":"23","author":"Baty","year":"2019","journal-title":"Cancer\/Radioth\u00e9rapie"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1417\u221228","DOI":"10.1002\/cncr.v110:7","article-title":"Patient selection, cancer control, and complications after salvage local therapy for postradiation prostate-specific antigen failure: A systematic review of the literature","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1\u22129","DOI":"10.5603\/RPOR.a2021.0129","article-title":"Special stereotactic radiotherapy techniques: procedures and equipment for treatment simulation and dose delivery","volume":"27","author":"Paoletti","year":"2022","journal-title":"Rep Pract Oncol Radiother"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.746853","article-title":"Biological bases of immune-related adverse events and potential crosslinks with immunogenic effects of radiation","volume":"12","author":"Bardoscia","year":"2021","journal-title":"Front Pharmacol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"2680","DOI":"10.3390\/cancers14112680","article-title":"Stereotactic body radiation therapy (SBRT) for oligorecurrent\/oligoprogressive mediastinal and hilar lymph node metastasis: A systematic review","volume":"14","author":"Cozzi","year":"2022","journal-title":"Cancers"},{"key":"B16","doi-asserted-by":"publisher","first-page":"4612\u221224","DOI":"10.3390\/curroncol29070366","article-title":"Can radiotherapy empower the host immune system to counterattack neoplastic cells? A systematic review on tumor microenvironment radiomodulation","volume":"29","author":"Iori","year":"2022","journal-title":"Curr Oncol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"3555\u221261","DOI":"10.21037\/apm-22-246","article-title":"How a very large sarcomatoid lung cancer was efficiently managed with lattice radiation therapy: a case report","volume":"11","author":"Iori","year":"2022","journal-title":"Ann Palliat Med"},{"key":"B18","doi-asserted-by":"publisher","first-page":"2995\u22123012","DOI":"10.3390\/curroncol29050244","article-title":"State of the art in combination immuno\/radiotherapy for brain metastases: systematic review and meta-analysis","volume":"29","author":"Najafi","year":"2022","journal-title":"Curr Oncol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"20200951","DOI":"10.1259\/bjr.20200951","article-title":"Brain metastases from primary colorectal cancer: is radiosurgery an effective treatment approach? Results of a multicenter study of the radiation and clinical oncology Italian association (AIRO)","volume":"93","author":"Navarria","year":"2020","journal-title":"Br J Radiol"},{"key":"B20","doi-asserted-by":"publisher","first-page":"947\u221256","DOI":"10.1080\/14737140.2020.1822742","article-title":"Prostate re-irradiation: current concerns and future perspectives","volume":"20","author":"Cuccia","year":"2020","journal-title":"Expert Rev Anticancer Ther"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2311\u22127","DOI":"10.1007\/s00432-020-03297-5","article-title":"PROLAPSE: survey about local prostate cancer relapse salvage treatment with external beam re-irradiation: results of the Italian Association of Radiotherapy and Clinical Oncology (AIRO)","volume":"146","author":"Zerini","year":"2020","journal-title":"J Cancer Res Clin Oncol"},{"key":"B22","doi-asserted-by":"publisher","first-page":"183\u221297","DOI":"10.1016\/j.euo.2018.12.011","article-title":"Nonsurgical salvage local therapies for radiorecurrent prostate cancer: A systematic review and meta-analysis","volume":"3","author":"Ingrosso","year":"2020","journal-title":"Eur Urol Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"291\u22128","DOI":"10.1016\/j.brachy.2016.12.011","article-title":"Salvage of locally recurrent prostate cancer after external beam radiation using reduced-dose brachytherapy with neoadjuvant plus adjuvant androgen deprivation","volume":"16","author":"Baumann","year":"2017","journal-title":"Brachytherapy"},{"key":"B24","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13014-017-0789-9","article-title":"Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy","volume":"12","author":"Mbeutcha","year":"2017","journal-title":"Radiat Oncol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2020\u22124","DOI":"10.1016\/j.juro.2006.07.008","article-title":"Combined prostate brachytherapy and short-term androgen deprivation therapy as salvage therapy for locally recurrent prostate cancer after external beam irradiation","volume":"176","author":"Wong","year":"2006","journal-title":"J Urol"},{"key":"B26","doi-asserted-by":"publisher","first-page":"1485\u221292","DOI":"10.1002\/cncr.v110:7","article-title":"Magnetic resonance image-guided salvage brachytherapy after radiation in select men who initially presented with favorable-risk prostate cancer: A prospective phase 2 study","volume":"110","author":"Nguyen","year":"2007","journal-title":"Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"668\u221274","DOI":"10.1007\/s00066-013-0373-7","article-title":"Protocol-based image-guided salvage brachytherapy: Early results in patients with local failure of prostate cancer after radiation therapy","volume":"189","author":"Lahmer","year":"2013","journal-title":"Strahlenther Onkol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"111\u22126","DOI":"10.1016\/j.brachy.2013.11.005","article-title":"A Phase II study of salvage high-dose-rate brachytherapy for the treatment of locally recurrent prostate cancer after definitive external beam radiotherapy","volume":"13","author":"Yamada","year":"2014","journal-title":"Brachytherapy"},{"key":"B29","doi-asserted-by":"publisher","first-page":"835\u22129","DOI":"10.1111\/j.1464-410X.2011.10519.x","article-title":"Salvage high-dose-rate brachytherapy for local prostate cancer recurrence after radiotherapy \u2013 preliminary results","volume":"109","author":"Jo","year":"2012","journal-title":"BJU Int"},{"key":"B30","first-page":"105\u22128","article-title":"HDR brachytherapy as a solution in recurrences of locally advanced prostate cancer","volume":"1","author":"\u0141yczek","year":"2009","journal-title":"J Contemp Brachyther"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1194\u2212201","DOI":"10.1177\/1533034617741797","article-title":"Focal MRI-guided salvage high-dose-rate brachytherapy in patients with radiorecurrent prostate cancer","volume":"16","author":"Maenhout","year":"2017","journal-title":"Technol Cancer Res Treat"},{"key":"B32","doi-asserted-by":"publisher","first-page":"339\u221244","DOI":"10.1177\/153303460300200409","article-title":"Salvage reimplantation in patient with local recurrent prostate carcinoma after brachytherapy with three dimensional computed tomography-guided permanent pararectal implant","volume":"2","author":"Koutrouvelis","year":"2003","journal-title":"Technol Cancer Res Treat"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1338\u221244","DOI":"10.1016\/j.ijrobp.2009.06.061","article-title":"Long-term outcome and toxicity of salvage brachytherapy for local failure after initial radiotherapy for prostate cancer","volume":"77","author":"Burri","year":"2010","journal-title":"Int J Radiat Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1\u22129","DOI":"10.1155\/2016\/9561494","article-title":"Salvage brachytherapy for biochemically recurrent prostate cancer following primary brachytherapy","volume":"2016","author":"Lacy","year":"2016","journal-title":"Prostate Cancer"},{"key":"B35","doi-asserted-by":"publisher","first-page":"77\u221282","DOI":"10.1016\/j.radonc.2014.06.013","article-title":"Focal salvage iodine-125 brachytherapy for prostate cancer recurrences after primary radiotherapy: A retrospective study regarding toxicity, biochemical outcome and quality of life","volume":"112","author":"Peters","year":"2014","journal-title":"Radiother Oncol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"53\u22128","DOI":"10.1016\/j.brachy.2013.10.012","article-title":"Salvage brachytherapy for recurrent prostate cancer","volume":"13","author":"Vargas","year":"2014","journal-title":"Brachytherapy"},{"key":"B37","doi-asserted-by":"publisher","first-page":"1405\u221216","DOI":"10.1002\/cncr.v110:7","article-title":"Management of prostate cancer recurrences after radiation therapy-brachytherapy as a salvage option","volume":"110","author":"Allen","year":"2007","journal-title":"Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"1106\u221212","DOI":"10.1016\/j.ijrobp.2006.10.012","article-title":"Feasibility of high-dose-rate brachytherapy salvage for local prostate cancer recurrence after radiotherapy: The University of California\u2013San Francisco experience","volume":"67","author":"Lee","year":"2007","journal-title":"Int J Radiat Oncol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"S310","DOI":"10.1016\/j.ijrobp.2008.06.1078","article-title":"Salvage permanent perineal radioactive seed implantation for the treatment of localized prostate adenocarcinoma recurrence after external beam radiation","volume":"72","author":"Aaronson","year":"2008","journal-title":"Int J Radiat Oncol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"324\u22129","DOI":"10.1016\/j.ijrobp.2013.01.027","article-title":"Salvage HDR brachytherapy for recurrent prostate cancer after previous definitive radiation therapy: 5-year outcomes","volume":"86","author":"Chen","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"B41","doi-asserted-by":"crossref","first-page":"294\u2212300","DOI":"10.1159\/000346322","article-title":"Salvage 125I seed implantation for prostate cancer with postradiation local recurrence","volume":"90","author":"Shimbo","year":"2013","journal-title":"Urol Int"},{"key":"B42","doi-asserted-by":"publisher","first-page":"165\u221270","DOI":"10.1007\/s00066-013-0486-z","article-title":"Salvage prostate HDR brachytherapy combined with interstitial hyperthermia for local recurrence after radiation therapy failure","volume":"190","author":"Kukie\u0142ka","year":"2014","journal-title":"Strahlenther Onkol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"117955491773876","DOI":"10.1177\/1179554917738765","article-title":"Salvage low dose rate brachytherapy for recurrent prostate cancer after external beam radiotherapy: results from A single institution with focus on toxicity and functional outcomes","volume":"11","author":"Barbera","year":"2017","journal-title":"Clin Med Insights Oncol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"119\u221225","DOI":"10.1016\/j.brachy.2009.06.007","article-title":"Treatment outcome and toxicity after salvage 125-I implantation for prostate cancer recurrences after primary 125-I implantation and external beam radiotherapy","volume":"9","author":"Moman","year":"2010","journal-title":"Brachytherapy"},{"key":"B45","doi-asserted-by":"publisher","first-page":"370\u22127","DOI":"10.1016\/j.ijrobp.2012.04.028","article-title":"Feasibility of MR imaging\/MR spectroscopy-planned focal partial salvage permanent prostate implant (PPI) for localized recurrence after initial PPI for prostate cancer","volume":"85","author":"Hsu","year":"2013","journal-title":"Int J Radiat Oncol"},{"key":"B46","doi-asserted-by":"publisher","first-page":"342\u22129","DOI":"10.1016\/j.brachy.2015.01.002","article-title":"Salvage low-dose-rate permanent seed brachytherapy for locally recurrent prostate cancer: Association between dose and late toxicity","volume":"14","author":"Rose","year":"2015","journal-title":"Brachytherapy"},{"key":"B47","doi-asserted-by":"publisher","first-page":"405\u221210","DOI":"10.1016\/j.radonc.2016.04.032","article-title":"Salvage high-dose-rate brachytherapy for locally recurrent prostate cancer after primary radiotherapy failure","volume":"119","author":"Wojcieszek","year":"2016","journal-title":"Radiother Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"628\u221236","DOI":"10.1007\/s00066-020-01628-6","article-title":"Linac-based SBRT as a feasible salvage option for local recurrences in previously irradiated prostate cancer","volume":"196","author":"Cuccia","year":"2020","journal-title":"Strahlenther Onkol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.858740","article-title":"1.5T MR-guided daily adaptive stereotactic body radiotherapy for prostate re-irradiation: A preliminary report of toxicity and clinical outcomes","volume":"12","author":"Cuccia","year":"2022","journal-title":"Front Oncol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"673\u221281","DOI":"10.1016\/j.adro.2018.06.001","article-title":"Salvage reirradiation for local failure of prostate cancer after curative radiation therapy: Association of rectal toxicity with dose distribution and normal-tissue complication probability models","volume":"3","author":"Dipasquale","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"442\u22129","DOI":"10.1016\/j.brachy.2014.05.001","article-title":"Use of a rectal spacer with low-dose-rate brachytherapy for treatment of prostate cancer in previously irradiated patients: Initial experience and short-term results","volume":"13","author":"Mahal","year":"2014","journal-title":"Brachytherapy"},{"key":"B52","doi-asserted-by":"publisher","first-page":"215\u22129","DOI":"10.1016\/j.radonc.2012.11.009","article-title":"Low rectal toxicity after dose escalated IMRT treatment of prostate cancer using an absorbable hydrogel for increasing and maintaining space between the rectum and prostate: Results of a multi-institutional phase II trial","volume":"106","author":"Uhl","year":"2013","journal-title":"Radiother Oncol"},{"key":"B53","doi-asserted-by":"publisher","first-page":"477\u221283","DOI":"10.1016\/j.brachy.2020.03.006","article-title":"Acute patient-reported bowel quality of life and rectal bleeding with the combination of prostate external beam radiation, low-dose-rate brachytherapy boost, and SpaceOAR","volume":"19","author":"Patel","year":"2020","journal-title":"Brachytherapy"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1494304\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T05:10:13Z","timestamp":1738213813000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1494304\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,30]]},"references-count":53,"alternative-id":["10.3389\/fonc.2025.1494304"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1494304","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,30]]},"article-number":"1494304"}}